The frequency of ALK negative tumor was observed in patients with resistance to crizotinib was 18.2% [23], given that the emergence of an ALK negative tumor was associated with other separate oncogenic drivers, or the percentage of positive cells in this case was not zero, consistent with background noise in the break apart FISH assay as previously described [7]. Here, ALK is linked to neoplasm.